Shambhavi, Shreya, et al. “Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis”. World Journal of Oncology, vol. 16, no. 4, July 2025, pp. 331-4, https://doi.org/10.14740/wjon2613.